Tag collegati:
Kollektivet som gick i kras
Dr. Rosalyn Juergens: What Novel Therapies Are You Most Optimistic About as Potential Lung Cancer Treatments in the Next Few Years?
Dr. David Spigel: What are the most promising targeted therapy approaches in lung cancer for the next few years?
Dr. Karen Reckamp on "Which patients do you send molecular marker testing for, and what tests do you seek?"
Drs. Ross Camidge and Corey Langer on "Which patients do you send molecular marker testing for, and what tests do you seek?"
Dr. Sarah Goldberg on "Which molecular marker tests do you seek?"
Drs. Ross Camidge and Corey Langer on "Which patients do you send molecular marker testing for?"
Dr. Greg Riely: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy
Dr. Heather Wakelee on "Which molecular marker tests do you seek?"
Dr. Ravi Salgia on "Which patients do you send molecular marker testing for, and what tests do you seek?"
Highlights in Lung Cancer, 2013: MEK Inhibitors for KRAS Mutation-Positive NSCLC (audio)
Squamous Lung Cancer, Part 2: Genomic Testing (video)
Highlights in Lung Cancer, 2013: MEK Inhibitors for KRAS Mutation-Positive NSCLC (video)
Dr. Geoffrey Oxnard on What Molecular Markers to Test for in Advanced NSCLC, and in Whom?
Dr. Rosalyn Juergens: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy
Squamous Lung Cancer Part 5, Q and A Session (video)
Drs. Ross Camidge and Corey Langer: How Do You Make Use of a Broad Molecular Profile Brought by a Patient?
Dr. Phil Bonomi: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy
Dr. Sarah Goldberg on "Which patients do you send molecular marker testing for?"
Dr. David Spigel on "Which molecular marker tests do you seek?"
Dr. Greg Riely on "Which patients do you send molecular marker testing for, and what tests do you seek?"
Can we target KRAS effectively in advanced NSCLC?
Squamous Lung Cancer, Part 2: Genomic Testing (audio)
Dr. Rosalyn Juergens: How Do You Discuss the Pros and Cons of Molecular Testing, with Potential Delays and Need for Rebiopsy?
Squamous Lung Cancer Part 5, Q and A Session (audio)
Targeting the RAF Pathway in Lung Cancer
What is the Value of Testing for Molecular Markers in Advanced NSCLC?
PODCAST-GRACEcast- Dr. Sandip Patel- Emerging Molecular Targets in NSCLC- KRAS
Finding Community After a Cancer Diagnosis: A Conversation with Terri Conneran
S1E8 - Teste di Carso con Roberto Terpin
Scopri di più
Cerca
